ScholarLens Back to search
2009•南京医科大学学报：英文版Requires access

Dipeptidyl peptidase IV(DPP IV): a novel emerging target for the treatment of type 2 diabetes

Jing Wu, Yiding Chen, Xiaoli Shi, Wei Gu

Open publisher page 16 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vildagliptin, Sitagliptin, Incretin, Postprandial, Dipeptidyl peptidase, Dipeptidyl peptidase-4, Saxagliptin, Type 2 diabetes

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Dipeptidyl peptidase IV(DPP IV): a novel emerging target for the treatment of type 2 diabetes — Research Paper | ScholarLens